Sign In
Book a Demo
Ranjana Advani, Other
About ProfilePoints™
0 Patient Reviews

Ranjana Advani, Other

Hematology / Oncology Specialist - Hematologist (Blood)

Highlights

  • Board Certified
  • Accepts Insurance Plans

Biography

Ranjana Advani, Other is a Hematology / Oncology Specialist - Hematologist (Blood) practicing in Palo Alto, CA

She has not yet shared a personalized biography with Doctor.com.

View Phone #Call Now

Are you Ranjana Advani, Other?

Claim your 100% free Doctor.com profile to:

  • Respond to patient reviews
  • Customize your profile
  • Improve your visibility to our millions of monthly users
Claim your profile

Provider Training

UniversityDegreeFocusGraduated
Butler University in IndianapolisMedical DegreeNot Specified
Bombay University, K.J. Somaiya Medical College And Research CentreMedical Degree1982
Grant Government Medical CollegeMedical Degree1982

InstitutionFocusYear
Internship - Santa Clara Valley Medical Center1987
Residency - Stanford University School of Medicine1990
Residency - Stanford University Program Not Specified
Fellowship - Stanford University School of Medicine,Stanford, Ca, United States1996

CertificationCert. BodyYear

Sub-Specialty: Medical Oncology		Internal Medicine1995

Experience & Accolades

Publication Publisher Title Published
Other PublicationLeukemia & lymphomaBevacizumab and cyclosphosphamide, doxorubicin2014
Other PublicationJournal of clinical oncologyMature Results of a Phase II Study of Rituximab Therapy for Nodular Lymphocyte2014
Other PublicationBloodPhase 2 study of VcR-CVAD with maintenance rituximab for untreated mantle cell lymphoma2014
Other PublicationBloodImprovements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades2013
Other PublicationNEW ENGLAND JOURNAL OF MEDICINETargeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma2013
Other PublicationJOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKTargeted Therapy in Relapsed Classical Hodgkin Lymphoma2013
Other PublicationBloodPlasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma2013
Other PublicationNEW ENGLAND JOURNAL OF MEDICINEDose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma2013
Other PublicationANNALS OF ONCOLOGYEfficacy of abbreviated Stanford V chemotherapy2013
Other PublicationBRITISH JOURNAL OF HAEMATOLOGYThe efficacy and tolerability of adriamycin, bleomycin2013
Other PublicationJOURNAL OF CLINICAL ONCOLOGYRandomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally2013
Other PublicationJOURNAL OF CLINICAL ONCOLOGYRisk of Therapy-Related Secondary Leukemia in Hodgkin Lymphoma2013
Other PublicationBLOODMulticenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma2013
Other PublicationJOURNAL OF CLINICAL ONCOLOGYBruton Tyrosine Kinase Inhibitor Ibrutinib2013
Other PublicationBLOODTumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma2012
Other PublicationJOURNAL OF CLINICAL ONCOLOGYPhase II Study of Rituximab Plus Cyclophosphamide, Doxorubicin2012
Other PublicationONCOLOGISTBrentuximab Vedotin in Transplant-Naive Patients with Relapsed or Refractory Hodgkin Lymphoma2012
Other PublicationJOURNAL OF CLINICAL ONCOLOGYBrentuximab Vedotin2012
Other PublicationLEUKEMIA & LYMPHOMACardiac toxicity associated with bevacizumab2012
Other PublicationINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSSTAGE I-IIIA NON-BULKY HODGKIN'S LYMPHOMA. IS FURTHER DISTINCTION BASED ON PROGNOSTIC FACTORS2011
Other PublicationCLINICAL CANCER RESEARCHMicroRNAs Are Independent Predictors of Outcome in Diffuse Large B2011
Other PublicationLEUKEMIA & LYMPHOMACurrent concepts and controversies in the management of early stage Hodgkin lymphoma2011
Other PublicationHematology / the Education Program of the American Society of HematoloOptimal therapy of advanced Hodgkin lymphoma.2011
Other PublicationAdvani, R. H., Chen, H., Habermann, T. M., Morrison, V. A., Weller, E.Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B2010
Other PublicationEXPERT REVIEW OF ANTICANCER THERAPYRisk stratification in extranodal natural killer/T-cell lymphoma2010
Other PublicationAlizadeh, A. A., Gentles, A. J., Alencar, A. J., Kohrt, H. E., Houot, Prediction of Survival in Diffuse Large B-Cell Lymphoma Based On the Expression of Two Genes2009
Other PublicationLANCET ONCOLOGYManagement of T-cell and natural-killer-cell neoplasms in Asia2009
Other PublicationJOURNAL OF CLINICAL ONCOLOGYPhase I Study of the Humanized Anti2009
Other PublicationJOURNAL OF CLINICAL ONCOLOGYImpact of positive positron emission tomography on prediction of freedom from progression after2007
Other PublicationLEUKEMIA & LYMPHOMAAngioimmunoblastic T cell lymphoma: Treatment experience with cyclosporine2007
Other PublicationJOURNAL OF CLINICAL ONCOLOGYStage I and II follicular non-Hodgkin's lymphoma: Long-term follow-up of no initial therapy2004
Other PublicationPediatric blood & cancerACR appropriateness Criteria® pediatric Hodgkin lymphoma.2014
Other PublicationBRITISH JOURNAL OF HAEMATOLOGYA multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era2014
Other PublicationONCOLOGY-NEW YORKACR APPROPRIATENESS CRITERIA (R) Localized Nodal Indolent Lymphoma2013
Other PublicationLEUKEMIA & LYMPHOMAA multicenter phase II trial to determine the safety2013
Other PublicationJOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKNon-Hodgkin's Lymphomas, Version 1.2013 Featured Updates to the NCCN Guidelines2013
Other PublicationJournal of the National Comprehensive Cancer NetworkNon-Hodgkin's lymphomas, version 1.2013.2013
Other PublicationJOURNAL OF CLINICAL ONCOLOGYGene Expression-Based Model Using Formalin2013
Other PublicationJournal of the National Comprehensive Cancer NetworkNon-Hodgkin's Lymphomas, version 3.2012.2012
Other PublicationJOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKNon-Hodgkin's Lymphomas, Version 3.2012 Featured Updates to the NCCN Guidelines2012
Other PublicationPLOS ONESingle Cell Profiling of Circulating Tumor Cells2012
Other PublicationJOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKHodgkin Lymphoma, Version 2.2012 Featured Updates to the NCCN Guidelines2012
Other PublicationRADIATION ONCOLOGYInterim-treatment quantitative PET parameters predict progression2012
Other PublicationBLOODIn situ vaccination against mycosis fungoides by intratumoral injection of a TLR92012
Other PublicationCLINICAL CANCER RESEARCHA Phase I Weekly Dosing Study of Brentuximab Vedotin in Patients with Relapsed2012
Other PublicationINVESTIGATIONAL NEW DRUGSPhase I trial of oblimersen (GenasenseA (R)) and gemcitabine2011
Other PublicationJournal of the National Comprehensive Cancer NetworkHodgkin lymphoma.2011
Other PublicationJOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKNCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma2011
Other PublicationBLOODPrediction of survival in diffuse large B2011
Other PublicationOBSTETRICS AND GYNECOLOGYLymphoma in Pregnancy Initially Diagnosed as Vaginal Intraepithelial Neoplasia and Lichen Planus2011
Other PublicationJOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKNon-Hodgkin's Lymphomas2011
Other PublicationJOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGYACR Appropriateness Criteria (R) on Hodgkin's Lymphoma-Unfavorable Clinical Stage I and II2011
Other PublicationSCIENCE TRANSLATIONAL MEDICINECD40 Pathway Activation Status Predicts Response to CD40 Therapy in Diffuse Large B Cell Lymphoma2011
Other PublicationAlizadeh, A. A., Gentles, A. J., Alencar, A. J., Kohrt, H. E., Houot, Prediction of Survival In Diffuse Large B2010
Other PublicationJOURNAL OF CLINICAL ONCOLOGYIn Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study2010
Other PublicationCURRENT PROBLEMS IN CANCERACR Appropriateness Criteria (R): Follow-Up of Hodgkin's Lymphoma2010
Other PublicationCLINICAL CANCER RESEARCHVoreloxin, a First-in-Class Anticancer Quinolone Derivative, in Relapsed2010
Other PublicationJOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKNon-Hodgkin's Lymphomas2010
Other PublicationJournal of the National Comprehensive Cancer NetworkNCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas.2010
Other PublicationBLOODInterim positron emission tomography scans in diffuse large B-cell lymphoma2010
Other PublicationBRITISH JOURNAL OF HAEMATOLOGYLymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival2010
Other PublicationCURRENT OPINION IN ONCOLOGYThe emerging role for rituximab in the treatment of nodular lymphocyte predominant Hodgkin lymphoma2009
Other PublicationARCHIVES OF DERMATOLOGYPrognostic Factors in Primary Cutaneous Anapl2009
Other PublicationGratzinger, D., Advani, R., Zhao, S., Talreja, N., Tibshirani, R. J., Prognostic significance of vascular endothelial growth factor (VEGF), VEGF receptors (VEGFR)
Other PublicationCLINICAL LYMPHOMA & MYELOMATargeting CD40 in Waldenstrom's Macroglobulinemia2009
Other PublicationLEUKEMIA & LYMPHOMAExtranodal natural killer/T-cell lymphoma: current concepts in biology and treatment2009
Other PublicationONCOLOGY RESEARCHDynamic CD8 T-Cell Responses to Tumor2009
Other PublicationJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIndolent primary cutaneous B-cell lymphoma: Experience using systemic rituximab2008
Other PublicationClinical advances in hematology & oncology : H&OEvaluation and management of angioimmunoblastic T-cell lymphoma2008
Other PublicationJournal of the National Comprehensive Cancer NetworkHodgkin disease/lymphoma.2008
Other PublicationBLOODParaffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with2008
Other PublicationJournal of the National Comprehensive Cancer NetworkBeyond the guidelines in the treatment of peripheral T-cell lymphoma: new drug development.2008
Other PublicationJournal of the National Comprehensive Cancer NetworkNon-Hodgkin's lymphomas.2008
Other PublicationCANCERNon-Hodgkin lymphoma of the breast2007
Other PublicationCRITICAL REVIEWS IN ONCOLOGY HEMATOLOGYTreatment of mantle cell lymphoma: Current approach and future directions2006
Other PublicationARCHIVES OF DERMATOLOGYStaging accuracy in mycosis fungoides2006
Other PublicationJournal of the National Comprehensive Cancer NetworkNon-Hodgkin's lymphoma. Clinical practice guidelines in oncology.2006
Other PublicationJournal of the National Comprehensive Cancer NetworkHodgkin disease/lymphoma. Clinical practice guidelines in oncology.2006
Other PublicationJournal of the National Comprehensive Cancer NetworkManagement of advanced stage Hodgkin lymphoma.2006
Other PublicationANNALS OF ONCOLOGYA phase I trial of liposomal doxorubicin, paclitaxel and valspodar (PSC-833)2005
Other PublicationINVESTIGATIONAL NEW DRUGSA phase I trial of aprinocarsen (ISIS 3521/LY900003)2005
Other PublicationInvestigational New Drugs,A phase I trial of aprinocarsen (ISIS 3521/LY900003)2005
Other PublicationJOURNAL OF CLINICAL ONCOLOGYMitoxantrone, etoposide2004
Other PublicationCLINICAL CANCER RESEARCHPhase I and pharmacokinetic study of BMS-188797, a new taxane analog2003
Other PublicationAdvani, R., Fisher, G. A., Lum, B. L., Hausdorff, J., Halsey, J., LitcA phase I trial of doxorubicin, paclitaxel2001
Other PublicationBloodTreatment of refractory1999
Other PublicationLeukemia & lymphomaBevacizumab and cyclosphosphamide, doxorubicin2014
Other PublicationJourl of clinical oncologyMature Results of a Phase II Study of Rituximab Therapy for Nodular Lymphocyte2014
Other PublicationBloodPhase 2 study of VcR-CVAD with maintence rituximab for untreated mantle cell lymphoma2014
Other PublicationNEW ENGLAND JOURL OF MEDICINETargeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma2013
Other PublicationJOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKTargeted Therapy in Relapsed Classical Hodgkin Lymphoma2013
Other PublicationBloodPlasma Epstein-Barr virus D predicts outcome in advanced Hodgkin lymphoma2013
Other PublicationNEW ENGLAND JOURL OF MEDICINEDose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastil B-Cell Lymphoma2013
Other PublicationANLS OF ONCOLOGYEfficacy of abbreviated Stanford V chemotherapy2013
Other PublicationBRITISH JOURL OF HAEMATOLOGYThe efficacy and tolerability of adriamycin, bleomycin2013
Other PublicationJOURL OF CLINICAL ONCOLOGYRandomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally2013
Other PublicationJOURL OF CLINICAL ONCOLOGYRisk of Therapy-Related Secondary Leukemia in Hodgkin Lymphoma2013
Other PublicationJOURL OF CLINICAL ONCOLOGYBruton Tyrosine Kise Inhibitor Ibrutinib2013
Other PublicationJOURL OF CLINICAL ONCOLOGYPhase II Study of Rituximab Plus Cyclophosphamide, Doxorubicin2012
Other PublicationONCOLOGISTBrentuximab Vedotin in Transplant-ive Patients with Relapsed or Refractory Hodgkin Lymphoma2012
Other PublicationJOURL OF CLINICAL ONCOLOGYBrentuximab Vedotin2012
Other PublicationLEUKEMIA & LYMPHOMACardiac toxicity associated with bevacizumab2012
Other PublicationINTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSSTAGE I-IIIA NON-BULKY HODGKIN'S LYMPHOMA. IS FURTHER DISTINCTION BASED ON PROGNOSTIC FACTORS2011
Other PublicationCLINICAL CANCER RESEARCHMicroRs Are Independent Predictors of Outcome in Diffuse Large B2011
Other PublicationLEUKEMIA & LYMPHOMACurrent concepts and controversies in the magement of early stage Hodgkin lymphoma2011
Other PublicationAdvani, R. H., Chen, H., Habermann, T. M., Morrison, V. A., Weller, E.Comparison of conventiol prognostic indices in patients older than 60 years with diffuse large B2010
Other PublicationEXPERT REVIEW OF ANTICANCER THERAPYRisk stratification in extranodal tural killer/T-cell lymphoma2010
Other PublicationLANCET ONCOLOGYMagement of T-cell and tural-killer-cell neoplasms in Asia2009
Other PublicationJOURL OF CLINICAL ONCOLOGYPhase I Study of the Humanized Anti2009
Other PublicationJOURL OF CLINICAL ONCOLOGYImpact of positive positron emission tomography2007
Other PublicationJOURL OF CLINICAL ONCOLOGYStage I and II follicular non-Hodgkin's lymphoma: Long-term follow-up of no initial therapy2004
Other PublicationBRITISH JOURL OF HAEMATOLOGYA multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era2014
Other PublicationLEUKEMIA & LYMPHOMAA multicenter phase II trial to determine the safety2013
Other PublicationJOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKNon-Hodgkin's Lymphomas, Version 1.2013 Featured Updates to the NCCN Guidelines2013
Other PublicationJourl of the tiol Comprehensive Cancer NetworkNon-Hodgkin's lymphomas, version 1.2013.2013
Other PublicationJOURL OF CLINICAL ONCOLOGYGene Expression-Based Model Using Formalin-Fixed Paraffin2013
Other PublicationJourl of the tiol Comprehensive Cancer NetworkNon-Hodgkin's Lymphomas, version 3.2012.2012
Other PublicationJOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKNon-Hodgkin's Lymphomas, Version 3.2012 Featured Updates to the NCCN Guidelines2012
Other PublicationPLOS ONESingle Cell Profiling of Circulating Tumor Cells2012
Other PublicationJOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKHodgkin Lymphoma, Version 2.2012 Featured Updates to the NCCN Guidelines2012
Other PublicationBLOODIn situ vaccition against mycosis fungoides by intratumoral injection of a TLR92012
Other PublicationINVESTIGATIOL NEW DRUGSPhase I trial of oblimersen (GesenseA (R)) and gemcitabine in refractory and advanced maligncies2011
Other PublicationJourl of the tiol Comprehensive Cancer NetworkHodgkin lymphoma.2011
Other PublicationJOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKNCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma2011
Other PublicationOBSTETRICS AND GYNECOLOGYLymphoma in Pregncy Initially Diagnosed as Vagil Intraepithelial Neoplasia and Lichen Planus2011
Other PublicationJOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKNon-Hodgkin's Lymphomas2011
Other PublicationJOURL OF THE AMERICAN COLLEGE OF RADIOLOGYACR Appropriateness Criteria (R) on Hodgkin's Lymphoma-Unfavorable Clinical Stage I and II2011
Other PublicationSCIENCE TRANSLATIOL MEDICINECD40 Pathway Activation Status Predicts Response to CD40 Therapy in Diffuse Large B Cell Lymphoma2011
Other PublicationJOURL OF CLINICAL ONCOLOGYIn Situ Vaccition With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study2010
Other PublicationJOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKNon-Hodgkin's Lymphomas2010
Other PublicationJourl of the tiol Comprehensive Cancer NetworkNCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas.2010
Other PublicationBRITISH JOURL OF HAEMATOLOGYLymphoma cell VEGFR2 expression detected2010
Other PublicationCURRENT OPINION IN ONCOLOGYThe emerging role for rituximab in the treatment of nodular lymphocyte predomint Hodgkin lymphoma2009
Other PublicationARCHIVES OF DERMATOLOGYPrognostic Factors in Primary Cutaneous Aplastic Large Cell Lymphoma2009
Other PublicationLEUKEMIA & LYMPHOMAExtranodal tural killer/T-cell lymphoma: current concepts in biology and treatment2009
Other PublicationONCOLOGY RESEARCHDymic CD8 T-Cell Responses to Tumor-Associated Epstein-Barr2009
Other PublicationJOURL OF THE AMERICAN ACADEMY OF DERMATOLOGYIndolent primary cutaneous B-cell lymphoma: Experience using systemic rituximab2008
Other PublicationClinical advances in hematology & oncology : H&OEvaluation and magement of angioimmunoblastic T-cell lymphoma2008
Other PublicationJourl of the tiol Comprehensive Cancer NetworkHodgkin disease/lymphoma.2008
Other PublicationJourl of the tiol Comprehensive Cancer NetworkBeyond the guidelines in the treatment of peripheral T-cell lymphoma: new drug development.2008
Other PublicationJourl of the tiol Comprehensive Cancer NetworkNon-Hodgkin's lymphomas.2008
Other PublicationJourl of the tiol Comprehensive Cancer NetworkNon-Hodgkin's lymphoma. Clinical practice guidelines in oncology.2006
Other PublicationJourl of the tiol Comprehensive Cancer NetworkHodgkin disease/lymphoma. Clinical practice guidelines in oncology.2006
Other PublicationJourl of the tiol Comprehensive Cancer NetworkMagement of advanced stage Hodgkin lymphoma.2006
Other PublicationANLS OF ONCOLOGYA phase I trial of liposomal doxorubicin, paclitaxel and valspodar (PSC-833)2005
Other PublicationINVESTIGATIOL NEW DRUGSA phase I trial of aprinocarsen (ISIS 3521/LY900003)2005
Other PublicationInvestigatiol New Drugs,A Phase I Trial of Aprinocarsen (ISIS 3521/LY900003)2005
Other PublicationJOURL OF CLINICAL ONCOLOGYMitoxantrone, etoposide2004
Other PublicationCLINICAL CANCER RESEARCHPhase I and pharmacokinetic study of BMS-188797, a new taxane alog2003
Other PublicationBloodTreatment of refractory1999

Practice & Hospital Affiliations

Ranjana Advani, Other has not yet indicated the hospitals that she is affiliated with.

Photos

Provider Profile 0

Specialties

Languages Spoken
English
Medical Specialties
  • Hematology / Oncology Specialist - Sub-Specialty: Hematologist (Blood)

Years In Practice: 35 (started in 1989)

Accepts New Patients: Yes

Accepted Insurance

Full Insurance List

Payment Options

Payment Details
We use cookies and limited processing of your personal information for our website and services to function. By using our site, you agree to our use of cookies and our privacy policy.
I Accept